chr3-64522219-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_182920.2(ADAMTS9):āc.5760A>Gā(p.Gly1920=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00295 in 1,614,062 control chromosomes in the GnomAD database, including 109 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.015 ( 46 hom., cov: 33)
Exomes š: 0.0017 ( 63 hom. )
Consequence
ADAMTS9
NM_182920.2 synonymous
NM_182920.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.14
Genes affected
ADAMTS9 (HGNC:13202): (ADAM metallopeptidase with thrombospondin type 1 motif 9) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. Members of the ADAMTS family have been implicated in the cleavage of proteoglycans, the control of organ shape during development, and the inhibition of angiogenesis. This gene is localized to chromosome 3p14.3-p14.2, an area known to be lost in hereditary renal tumors. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-64522219-T-C is Benign according to our data. Variant chr3-64522219-T-C is described in ClinVar as [Benign]. Clinvar id is 791933.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0503 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS9 | NM_182920.2 | c.5760A>G | p.Gly1920= | synonymous_variant | 39/40 | ENST00000498707.5 | NP_891550.1 | |
ADAMTS9 | NM_001318781.2 | c.5676A>G | p.Gly1892= | synonymous_variant | 38/39 | NP_001305710.1 | ||
ADAMTS9 | XR_007095711.1 | n.6019A>G | non_coding_transcript_exon_variant | 38/40 | ||||
ADAMTS9 | XR_245151.1 | n.6103A>G | non_coding_transcript_exon_variant | 39/41 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS9 | ENST00000498707.5 | c.5760A>G | p.Gly1920= | synonymous_variant | 39/40 | 1 | NM_182920.2 | ENSP00000418735 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0148 AC: 2248AN: 152214Hom.: 44 Cov.: 33
GnomAD3 genomes
AF:
AC:
2248
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00396 AC: 995AN: 251380Hom.: 22 AF XY: 0.00309 AC XY: 420AN XY: 135854
GnomAD3 exomes
AF:
AC:
995
AN:
251380
Hom.:
AF XY:
AC XY:
420
AN XY:
135854
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00171 AC: 2504AN: 1461730Hom.: 63 Cov.: 30 AF XY: 0.00152 AC XY: 1105AN XY: 727170
GnomAD4 exome
AF:
AC:
2504
AN:
1461730
Hom.:
Cov.:
30
AF XY:
AC XY:
1105
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0149 AC: 2265AN: 152332Hom.: 46 Cov.: 33 AF XY: 0.0150 AC XY: 1116AN XY: 74488
GnomAD4 genome
AF:
AC:
2265
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
1116
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at